Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 08:14:07 +0200Thu, 06 Jun 2024 10:52:00 +0200Human medicines European public assessment report (EPAR): Qdenga, dengue tetravalent vaccine (live, attenuated), Date of authorisation: 05/12/2022, Revision: 1, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/qdengaHuman medicines European public assessment report (EPAR): Qdenga, dengue tetravalent vaccine (live, attenuated), Date of authorisation: 05/12/2022, Revision: 1, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/qdengaThu, 06 Jun 2024 10:52:00 +0200Human medicineQdenga : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5155-en.pdfQdenga : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5155-en.pdfThu, 06 Jun 2024 10:09:00 +0200Human medicine